DISCOUNT ZERTIFIKAT - CVS HEALTH Stock

Certificat

DE000ME7GJG9

Market Closed - Börse Stuttgart 12:44:14 2024-06-07 pm EDT
54.3 EUR +1.70% Intraday chart for DISCOUNT ZERTIFIKAT - CVS HEALTH
Current month+3.94%
1 month+6.97%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-07 54.3 +1.70%
24-06-06 53.39 +0.02%
24-06-05 53.38 +0.83%
24-06-04 52.94 +0.51%
24-06-03 52.67 +0.82%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 12:44 pm EDT

More quotes

Static data

Product typeDiscount Certificates
Buy / SellCALL
Underlying CVS HEALTH CORPORATION
Issuer Morgan Stanley
WKN ME7GJG
ISINDE000ME7GJG9
Date issued 2024-01-24
Maturity 2024-09-20 (104 Days)
Parity 1 : 1
Emission price 56.81
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 58.06
Lowest since issue 48.51

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
61.78 USD
Average target price
69.02 USD
Spread / Average Target
+11.72%
Consensus